This is reflected in widespread research regarding biochemical and imaging biomarkers use in diagnostics, whose presence, confirming the pathology of beta-amyloid and tau protein, strongly facilitates the diagnosis of Alzheimer disease [37]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.